These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16647984)
1. Factors contributing to nasal allergic late phase eosinophilia. Kramer MF; Jordan TR; Klemens C; Hilgert E; Hempel JM; Pfrogner E; Rasp G Am J Otolaryngol; 2006; 27(3):190-9. PubMed ID: 16647984 [TBL] [Abstract][Full Text] [Related]
2. [Clinical symptoms and mediators in the allergic early and late phase reaction]. Jordan TR; Pfrogner E; Rasp G; Kramer MF Laryngorhinootologie; 2006 Feb; 85(2):113-23. PubMed ID: 16498540 [TBL] [Abstract][Full Text] [Related]
3. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]
5. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge. Wagenmann M; Schumacher L; Bachert C Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297 [TBL] [Abstract][Full Text] [Related]
6. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Weido AJ; Reece LM; Alam R; Cook CK; Sim TC Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780 [TBL] [Abstract][Full Text] [Related]
7. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327 [TBL] [Abstract][Full Text] [Related]
8. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Kramer MF; Ostertag P; Pfrogner E; Rasp G Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Baumann R; Rabaszowski M; Stenin I; Tilgner L; Scheckenbach K; Wiltfang J; Schipper J; Chaker A; Wagenmann M Am J Rhinol Allergy; 2013; 27(4):266-72. PubMed ID: 23883806 [TBL] [Abstract][Full Text] [Related]
10. An approach of immunoneurological aspects in nasal allergic late phase. Jordan TR; Rasp G; Pfrogner E; Kramer MF Allergy Asthma Proc; 2005; 26(5):382-90. PubMed ID: 16450573 [TBL] [Abstract][Full Text] [Related]
11. IL-13 is essential to the late-phase response in allergic rhinitis. Miyahara S; Miyahara N; Matsubara S; Takeda K; Koya T; Gelfand EW J Allergy Clin Immunol; 2006 Nov; 118(5):1110-6. PubMed ID: 17088137 [TBL] [Abstract][Full Text] [Related]
12. Eosinophil infiltration and activation in nasal polyposis. Fan GK; Wang H; Takenaka H Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479 [TBL] [Abstract][Full Text] [Related]
13. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Nonaka M; Pawankar R; Fukumoto A; Ogihara N; Sakanushi A; Yagi T Clin Exp Allergy; 2004 May; 34(5):804-11. PubMed ID: 15144475 [TBL] [Abstract][Full Text] [Related]
15. [Acoustic rhinometry: measuring the early and late phase of allergic immediate reaction in allergic rhinitis]. Rasp G Laryngorhinootologie; 1993 Mar; 72(3):125-30. PubMed ID: 8471095 [TBL] [Abstract][Full Text] [Related]
16. Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves. Sheahan P; Walsh RM; Walsh MA; Costello RW Clin Exp Allergy; 2005 Jan; 35(1):45-51. PubMed ID: 15649265 [TBL] [Abstract][Full Text] [Related]
17. [Acoustic rhinometry: determination of early and late-phase reactions in allergic rhinitis]. Bujía J; Rasp G Acta Otorrinolaringol Esp; 1997; 48(1):31-5. PubMed ID: 9131923 [TBL] [Abstract][Full Text] [Related]
18. Skin tests, T cell responses and self-reported symptoms in children with allergic rhinitis and asthma due to house dust mite allergy. Moed H; van Wijk RG; de Jongste JC; van der Wouden JC Clin Exp Allergy; 2009 Feb; 39(2):222-7. PubMed ID: 19032359 [TBL] [Abstract][Full Text] [Related]
19. Allergen-induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of interleukin-4 and sVCAM-1. Fernvik E; Halldén G; Lundahl J; Raud J; Alkner U; van Hage-Hamsten M; Grönneberg R Allergy; 1999 May; 54(5):455-63. PubMed ID: 10380776 [TBL] [Abstract][Full Text] [Related]
20. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]